PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Summary Background In patients with locally advanced adenocarcinoma of the oesophagogastric junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([18 F]FDG-PET) during neoadjuvant chemotherapy is predictive of histopathological response and survival. We aimed to assess the f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2007-09, Vol.8 (9), p.797-805
Hauptverfasser:	Lordick, Florian, Dr, Ott, Katja, MD, Krause, Bernd-Joachim, Prof, Weber, Wolfgang A, MD, Becker, Karen, MD, Stein, Hubert J, Prof, Lorenzen, Sylvie, MD, Schuster, Tibor, MS, Wieder, Hinrich, MD, Herrmann, Ken, MD, Bredenkamp, Rainer, BSc, Höfler, Heinz, Prof, Fink, Ulrich, Prof, Peschel, Christian, Prof, Schwaiger, Markus, Prof, Siewert, Jörg R, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - diagnostic imaging Adenocarcinoma - therapy Aged Algorithms Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Esophageal Neoplasms - diagnostic imaging Esophageal Neoplasms - therapy Esophagogastric Junction Feasibility Studies Female Fluorodeoxyglucose F18 Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Neoadjuvant Therapy Positron-Emission Tomography Prognosis Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!